Skip to content

EV / EBITDA at other companies

Abbott logo
AbbottABT
18.9×-4.1×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12×+0.4×
Pfizer logo
PfizerPFE
12.9×
Procter & Gamble logo
Procter & GamblePG
15×-3.6×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×
Stryker logo
StrykerSYK
22.1×-11.8×

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.4%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+32.0%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$563.77B+47.3%
Enterprise value$597.07B+50.5%
P/E26.8×+9.3×
P/S5.9×+1.6×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Calculated from Johnson & Johnson’s reported figures.

Based on the most recent quarter.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's EV / EBITDA?
Johnson & Johnson (JNJ) reported EV / EBITDA of 18.8× in Q1 2026.
How has Johnson & Johnson's EV / EBITDA changed year-over-year?
Johnson & Johnson's EV / EBITDA increased by 28.7% year-over-year, from 14.6× to 18.8×.
What is the long-term trend for Johnson & Johnson's EV / EBITDA?
Over 4 years (2021 to 2025), Johnson & Johnson's EV / EBITDA has grown at a -1.6% compound annual growth rate (CAGR), from 63.9× to 59.8×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.